©2009 Precision Therapeutics, Inc. All rights reserved. | 2516 Jane Street, Pittsburgh, PA 15203
Her cancer is being treated with 10 different chemotherapies.
But she isn't.
By testing for relevant targets within a patient's tumor before treating a cancer patient, BioSpeciFxSM can be used in combination with ChemoFx® to help determine the chemotherapies that are more likely to be effective and guide physicians away from therapies that are more likely to be ineffective - giving patients a powerful advantage in the fight against cancer.But she isn't.
What is BioSpeciFx?
BioSpeciFxSM is a select group of clinically relevant and validated biomarker tests associated with drug response and patient prognosis. When used in combination with ChemoFx®, physicians can create a Comprehensive Tumor Profile, which may allow them to more completely define their patient's cancer.
